319 related articles for article (PubMed ID: 23544417)
1. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2013 Apr; 53(4):809-20. PubMed ID: 23544417
[TBL] [Abstract][Full Text] [Related]
2. Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2014 Oct; 54(10):2784-93. PubMed ID: 25191977
[TBL] [Abstract][Full Text] [Related]
3. Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
Bioorg Med Chem Lett; 2013 Sep; 23(18):5145-9. PubMed ID: 23920437
[TBL] [Abstract][Full Text] [Related]
4. Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
Bioorg Med Chem Lett; 2016 Feb; 26(4):1218-23. PubMed ID: 26810265
[TBL] [Abstract][Full Text] [Related]
5. Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approaches.
Sasikala D; Jeyakanthan J; Srinivasan P
J Recept Signal Transduct Res; 2016 Oct; 36(5):515-30. PubMed ID: 26795501
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
7. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deniz U; Ozkirimli E; Ulgen KO
J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
[TBL] [Abstract][Full Text] [Related]
8. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
[TBL] [Abstract][Full Text] [Related]
9. Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening.
Kumar A; Ito A; Takemoto M; Yoshida M; Zhang KY
J Chem Inf Model; 2014 Mar; 54(3):870-80. PubMed ID: 24512059
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening.
Zhong HJ; Ma VP; Cheng Z; Chan DS; He HZ; Leung KH; Ma DL; Leung CH
Biochimie; 2012 Nov; 94(11):2457-60. PubMed ID: 22709868
[TBL] [Abstract][Full Text] [Related]
12. Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies.
Aydin G; Paksoy MN; Orhan MD; Avsar T; Yurtsever M; Durdagi S
Chem Biol Drug Des; 2020 Jul; 96(1):684-700. PubMed ID: 32691963
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
14. Ligand efficiency based approach for efficient virtual screening of compound libraries.
Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
[TBL] [Abstract][Full Text] [Related]
15. Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.
Li YJ; Du L; Wang J; Vega R; Lee TD; Miao Y; Aldana-Masangkay G; Samuels ER; Li B; Ouyang SX; Colayco SA; Bobkova EV; Divlianska DB; Sergienko E; Chung TDY; Fakih M; Chen Y
Cell Chem Biol; 2019 Feb; 26(2):278-288.e6. PubMed ID: 30581133
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
Daga PR; Polgar WE; Zaveri NT
J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
[TBL] [Abstract][Full Text] [Related]
17. SUMO-mimicking peptides inhibiting protein SUMOylation.
Zhao B; Villhauer EB; Bhuripanyo K; Kiyokawa H; Schindelin H; Yin J
Chembiochem; 2014 Dec; 15(18):2662-6. PubMed ID: 25412743
[TBL] [Abstract][Full Text] [Related]
18. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
[TBL] [Abstract][Full Text] [Related]
19. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics in drug design.
Zhao H; Caflisch A
Eur J Med Chem; 2015 Feb; 91():4-14. PubMed ID: 25108504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
